The Way Forward for Foreign Investment under New Healthcare Policies: Prospects and Challenges in the Fields of Stem Cell and Gene Therapy and Wholly Foreign Owned Hospitals

The article outlines the background of the introduction of China’s new healthcare policies, highlighting the risks for foreign enterprises invest ment under these regulations and the impact of US legislation on biotechnology and data security. By strategically planning and allocating resources from the outset, foreign enterprises can expect significant returns in the medium to long term , thanks to progressive implemen ta t ion of policies and sustained growth of market demands.